A new market research study by Transparency Market Research presents an in-depth analysis of the global viscosupplementation market, emphasizing on the current trends and major growth prospects. The research study, titled “Viscosupplementation Market – Global Industry Analysis, Size, Share, Trends and Forecast 2016 – 2023,” covers the key drivers, restraints, product segmentation, geographical segmentation, and competitive scenario. The research report draws from analytical tools to determine the opportunities and challenges in the global viscosupplementation market.
Download exclusive Brochure of this report:
Osteoarthritis is considered as one of the most common forms of arthritis, affecting millions of people across the globe. As of now, there is no complete cure available for osteoarthritis of the knee; however, numerous treatment options help in slowing down the condition’s progression. In the initial stage, osteoarthritis is treated by non-surgical methods, however if the patient still observes pain then doctors consider the option of viscosupplementation. In this process, a gel-like fluid, known as hyaluronic acid, is injected into the knee joint of the patient. This fluid acts as a lubricant allowing the bones to move easily over each other.
The growing awareness regarding the new drugs and innovative devices available for treating osteoarthritis are the key factors projected to drive the global viscosupplementation market throughout the forecast period. In addition, the growing geriatric population, increasing obese population, and rising demand for minimally invasive surgical processes are some of the other factors estimated to fuel the growth of the market in the next few years. Process development and product innovation are further contributing substantially towards the growth of the global viscosupplementation market.
View exclusive Global strategic Business report:
At present, North America accounts for the largest share in the global viscosupplementation market owing to the growing awareness regarding the treatments available and rising product demand. On the other hand, the Europe viscosupplementation market is witnessing a significant fall in the market share due to the rising difficulties in reimbursement policies. However, this region is projected to witness a revival and create potential opportunities for viscosupplementation products in the forecast period. Furthermore, the Asia Pacific and Rest of the World viscosupplementation markets are anticipated to witness significant growth in the near future, thanks to the improving healthcare facilities and economic development here.
The prominent players operating in the global viscosupplementation market include Fidia Farmaceutici SpA, GALDERMA S.A., Ferring Pharmaceuticals, Inc., Hyaltech Ltd., LifeCore Biomedical LLC, F. Hoffmann-La Roche Ltd., Alcon, Inc., Anika Therapeutics, Inc., and Allergan, Inc. The report has provided detailed vendor analysis and profiles of the leading players in order to present a clear understanding of the global viscosupplementation market. The growing demand for viscosupplementation procedures is expected to encourage the entry of new market players in the coming years.